Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alport Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT03749447
What this trial is testing

An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE)

Who this might be right for
Chronic Kidney DiseasesAlport SyndromeAutosomal Dominant Polycystic Kidney
Biogen 270
Not applicableStudy completedNCT00481130
What this trial is testing

Alport Syndrome Treatments and Outcomes Registry

Who this might be right for
Alport Syndrome
University of Minnesota 655
Not applicableLooking for participantsNCT07575347
What this trial is testing

Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE)

Who this might be right for
Periodontal DiseasePeriodontitisCKD+6 more
Stefan Lujinschi 100
Not applicableActive Not RecruitingNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Not applicableEnded earlyNCT02718027
What this trial is testing

Biomarker for Alport Syndrome (BioAlport)

Who this might be right for
Nephritis, HereditaryHematuria-Nephropathy-Deafness Syndrome
CENTOGENE GmbH Rostock 12
Testing effectiveness (Phase 2)Study completedNCT00309257
What this trial is testing

Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome

Who this might be right for
Alport Syndrome
Mario Negri Institute for Pharmacological Research 9
Testing effectiveness (Phase 2)Looking for participantsNCT07523581
What this trial is testing

EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren Efficacy and Safety

Who this might be right for
Alport Syndrome, X-LinkedAlport Syndrome, Autosomal Recessive
Eloxx Pharmaceuticals, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT05267262
What this trial is testing

Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis

Who this might be right for
Alport SyndromeFocal Segmental Glomerulosclerosis
River 3 Renal Corp. 43
Testing effectiveness (Phase 2)Ended earlyNCT02855268
What this trial is testing

Study of Lademirsen (SAR339375) in Patients With Alport Syndrome

Who this might be right for
Alport Syndrome
Genzyme, a Sanofi Company 43
Testing effectiveness (Phase 2)Study completedNCT06425055
What this trial is testing

Vonafexor ALPort Syndrome Efficacy & Safety TRIAl-1 (ALPESTRIA-1)

Who this might be right for
Alport Syndrome
Enyo Pharma 26
Large-scale testing (Phase 3)Looking for participantsNCT05944016
What this trial is testing

Phase 3 Clinical Trial with Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients

Who this might be right for
Chronic Kidney Failure in Children and Young Adults
University Hospital Goettingen 102
Large-scale testing (Phase 3)Not Yet RecruitingNCT06731192
What this trial is testing

Human Umbilical Cord Mesenchymal Stem Cells for Alport Syndrome

Who this might be right for
Alport Syndrome
Guangzhou Women and Children's Medical Center 40
Not applicableLooking for participantsNCT02378805
What this trial is testing

Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome

Who this might be right for
Alport SyndromeHereditary Kidney DiseasePediatric Kidney Disease+2 more
University Hospital Goettingen 800
Not applicableStudy completedNCT01705132
What this trial is testing

Urinary Biomarkers of the Progression of Alport Kidney Disease

Who this might be right for
Alport Syndrome
University of Minnesota 80
Not applicableStudy completedNCT00622544
What this trial is testing

A Prospective Study of Microalbuminuria in Untreated Boys With Alport Syndrome

Who this might be right for
Alport SyndromeKidney Disease
University of Minnesota 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT04573920
What this trial is testing

Atrasentan in Patients With Proteinuric Glomerular Diseases

Who this might be right for
IgA NephropathyFocal Segmental GlomerulosclerosisAlport Syndrome+3 more
Novartis Pharmaceuticals 103
Not applicableStudy completedNCT01696253
What this trial is testing

Multi-center Controlled Clinical Trials in Alport Syndrome-A Feasibility Study

Who this might be right for
Alport Syndrome
University of Minnesota 360
Testing effectiveness (Phase 2)Study completedNCT05448755
What this trial is testing

ELX-02 in Patients With Alport Syndrome

Who this might be right for
Alport Syndrome
Eloxx Pharmaceuticals, Inc. 3
Post-approval studies (Phase 4)Study completedNCT06499948
What this trial is testing

Albuminuria Lowering Effect of Dapagliflozin, Spironolactone and Their Combination in Adult Patients With Alport Syndrome (COMBINE-ALPORT)

Who this might be right for
Alport SyndromeThin Basement Membrane DiseaseAlport Nephropathy
Stefan Lujinschi 12